spacer
home > pmps > autumn 2008 > labelling: clarity and compliance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Labelling: Clarity and Compliance

The legislation surrounding the clear and accurate labelling of pharmaceuticals, and the inclusion, where appropriate, of accompanying instruction leaflets, is becoming increasingly stringent. As a consequence, in addition to having to include mandatory information on medicinal products, pharmaceutical manufacturers and packaging companies are now required to ensure that this information is legible, easy to understand, and indelible. In order to achieve this using conventional printing technology, considerable time, money and resources can be required, leading these companies to look for a simpler and more cost-effective alternative.

Thankfully, a new generation of easy to operate and cost-effective printing equipment has been developed in response to these requirements, enabling the standards to be met with minimal expenditure and stress. Furthermore, these latest printers provide a sustainable solution, able to cater for evolving regulations and standards in order that they can continue to meet user requirements in the long term.

STRINGENT REGULATIONS

OEMs and packaging companies must now comply with the European Parliament Directive 2001/83/EC, which provides a number of guidelines concerning labelling pharmaceuticals and providing supporting documentation...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Mark Beauchamp is European Marketing Manager for Citizen Systems Europe. With over 18 years’ experience at the company and a wealth of technical knowledge, he is adept at helping channel partners and endusers alike to understand the latest printing technology. Beginning his career in the marketing team, Mark then moved into technical support where he provided distributor support across the European network. In addition to working with Citizen’s clients across Europe, the Middle East and Africa, he is actively involved in product development. Mark is Chairman of AIM UK, the British chapter of the Auto-ID manufacturers’ association.
spacer
Mark Beauchamp
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Surge of Indian biosimilars market forecast in 2019

16th April 2019: New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India specific findings from CPhI’s bio league tables predict strong ‘bio growth potential’ in India throughout 2019 in the build-up to the 13th edition of CPhI India 2019, which will take place at the India Expo Centre in Delhi NCR.
More info >>

White Papers

Another Successful Visit Against the Odds

Medical Research Network (MRN) Limited

Our dedicated team of nurses, couriers and project managers deliver, come rain or shine. Making sure a Clinical Trial visit can go ahead in the home can be a complex process, and last month bad weather nearly stopped play on an important Home Trial Support visit. Thanks to the commitment and dedication from the entire team it went ahead against the odds.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement